Health Products

Atropine Injection BP 0.4MG/ML (2015-11-19)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
50187
Recalling Firm
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA
Marketing Authorization Holder
Alveda Pharmaceutical Inc.
Suite 1100, 21 St. Clair Avenue East,
Toronto
M4T 1L9
Ontario
CANADA
Atropine Injection BP 0.4MG/MLSolutionDIN 02094681Atropine sulfate 0.4 mg/mL

Introduction

Affected Products

Atropine Injection BP 0.4MG/ML

Reason

One lot of Atropine Injection BP 0.4 mg/mL (DIN 02094681) (L) 50187 marketed and sold by Alveda Pharmaceuticals Inc. is being recalled, due to an incorrect barcode on the ampoule label. The barcode reads (01)00837641000591 which is that same barcode as on the ampoule label of Alveda Epinephrine Injection USP 1 mg/mL (DIN 02325225).

Depth of distribution

Wholesalers and sub-recall to physicians, hospitals and hospital Pharmacists in Alberta, British Columbia, Ontario, New Brunswick, Newfoundland, Nova Scotia, Manitoba, Quebec, and Saskatchewan.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime